ArabMedicare.com: The Web Portal for Healthcare Professionals


Livx | 8-10 December 2026 | Dubai, UAE

   Medical News Center 

  Home Page
Channels
 
Medical News Center
  Conference News
  Special Interviews
   
   
Rankings/Surveys
 

 

   
 
 
 
 
 

 

 
 
 

 

 

Sunday, 22 November 2026 | Conference News | Staff Reporter

 
 





BioPharma Deals 2026 to focus on licensing, M&A and strategic partnerships

 

(MUNICH) - The biopharmaceutical industry is facing a changing dealmaking environment as companies reassess their pipelines, seek external innovation and explore new approaches to financing and strategic growth. These developments will form part of the agenda at BioPharma Deals 2026, scheduled to take place on 24–25 November in Munich, Germany.

The conference is expected to bring together professionals working across business development, licensing, corporate development, investment, mergers and acquisitions (M&A), and strategic partnerships. Discussions will examine commercial and investment opportunities across the biotechnology and pharmaceutical sectors, alongside the factors influencing deal activity.

Topics on the agenda include licensing and partnering, M&A, co-development agreements, investment, due diligence, asset valuation, and strategic transactions. Sessions will address current market conditions and the considerations shaping negotiations and collaboration between biopharmaceutical companies.

A structured one-to-one partnering program is also planned, with more than 500 meetings expected during the two-day event. The program is intended to connect organizations exploring potential transactions, including emerging biotechnology companies seeking development or commercialization partners and pharmaceutical companies assessing external assets and technologies.

Attendees are expected to include representatives from pharmaceutical and biotechnology companies, investment firms, advisory organizations, and other participants in the life sciences transaction market.

Strategic priorities shape biopharma deal activity

The current market environment is placing greater emphasis on selectivity and strategic alignment in biopharmaceutical dealmaking. Companies are increasingly assessing external opportunities against pipeline priorities, commercial objectives, development capabilities, and longer-term portfolio strategies.

For biotechnology companies seeking partners or investment, scientific potential remains important, but it is only one part of the assessment. Development plans, clinical data, differentiation, commercial prospects, and funding requirements can all influence the attractiveness of an asset or company to potential partners.

For pharmaceutical companies, external innovation continues to provide a route to accessing new technologies, therapeutic candidates, and development capabilities. However, decisions around licensing and acquisitions also require consideration of portfolio fit, development risk, competitive positioning, and the potential commercial value of an opportunity.

These pressures are contributing to a broader role for business development teams. In addition to identifying and negotiating individual transactions, these professionals are increasingly involved in portfolio planning, market intelligence, competitive analysis, and the development of longer-term relationships with potential partners.

Against this backdrop, BioPharma Deals 2026 will address the commercial and strategic considerations influencing transactions across the biopharmaceutical sector. The conference will take place in Munich on 24–25 November 2026.

Further information about the conference program, speakers and registration is available at: https://www.biopharmadeals.com/

                                       
                                                                                   
                                    
 

 

 

 

PRINT THIS ARTICLE

 
 




International Hospital Federation


 

 

Home  | Search | About Us  | Education  | Business  | Health Centers | Clinical Resources  | Job Bank | Medical News |Conference News & Analysis | Events | Products/Services Showcase | Advertise With Us | Contact Us


Copyright © 1999-2026  ArabMedicare.com.  All rights reserved.